https://www.selleckchem.com/pr....oducts/alofanib-rpt8
s case series suggests that the risk for AIS is higher in adults 50 years or younger during the convalescent period of a COVID-19 infection without respiratory symptoms. Acute ischemic stroke could be part of the next wave of complications of COVID-19, and stroke units should be on alert and use serological testing, especially in younger patients or in the absence of traditional risk factors. This case series suggests that the risk for AIS is higher in adults 50 years or younger during the convalescent period of a COVID-19 infec
Aimer
Commentaire
Partagez
